new_0222_0431|ABOS|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0431|ABOS|1|Acumen Pharmaceuticals Inc PS Ratio|Acumen Pharmaceuticals Inc Price to Book Value|Acumen Pharmaceuticals Inc PEG Ratio|Acumen Pharmaceuticals Inc Price (USD)|Acumen Pharmaceuticals Inc Short Interest|Acumen Pharmaceuticals Inc Dividend Yield|Acumen Pharmaceuticals Inc Earnings Yield|Acumen Pharmaceuticals Inc Market Cap (USD)|Acumen Pharmaceuticals Inc PE Ratio|Acumen Pharmaceuticals Inc Consensus Recommendation|Acumen Pharmaceuticals Inc Price Target Num Estimates|Acumen Pharmaceuticals Inc Price Target (USD)|Acumen Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Acumen Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Acumen Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Acumen Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Acumen Pharmaceuticals Inc EBITDA Estimates for Current Fiscal Year (USD)|Acumen Pharmaceuticals Inc EBITDA Estimates for Next Fiscal Year (USD)|Acumen Pharmaceuticals Inc Revenue (Quarterly) (USD)|Acumen Pharmaceuticals Inc EBITDA (Quarterly) (USD)|Acumen Pharmaceuticals Inc Net Income (Quarterly) (USD)||
new_0222_0431|ABOS|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0431|ABOS|4|daily|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|quarterly|monthly|quarterly|quarterly|quarterly||
new_0222_0431|ABOS|5|1.44099378882|1.4387755102||1.44099378882|15.3846153846|1.44099378882|1.44099378882|1.44099378882||24.5|49|49|116|38.6666666667|49|32.6666666667|44.75|29|91.6666666667|91.3333333333|91.3333333333||
new_0222_0431|ABOS|6|161|98||161|13|161|161|161||8|4|4|1|3|4|6|4|4|3|6|6||
new_0222_0431|ABOS|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0431|ABOS|20200315|||||||||||||||||||0.226|-2.046|-2.045||
new_0222_0431|ABOS|20200615|||||||||||||||||||0.151|-2.035|-2.035||
new_0222_0431|ABOS|20200915|||||||||||||||||||0.73|-2.49|-2.49||
new_0222_0431|ABOS|20201215|||||||||||||||||||0.329|-1.342|-0.755||
new_0222_0431|ABOS|20210315||||||||||||||||||||-3.793|-26.997||
new_0222_0431|ABOS|20210615||||||||||||||||||||-3.441|-61.358||
new_0222_0431|ABOS|20210715|436.0384|||20.1|6382||-9.5657|776.9012||1.75|4|25|0.6582|0.5983|-0.6309|-1.3572|-20.8023|-30.8422||||20.28|15.48
new_0222_0431|ABOS|20210815|331.259|||15.27|2616||-12.5914|613.118||1.75||||||-2.4|-26|-30.8422||||14.95|17.92
new_0222_0431|ABOS|20210915|375.0798|2.5771||17.29|139177||-11.1203|699.6934||||||||||||-3.879|-3.902|15.27|14.86
new_0222_0431|ABOS|20211015|356.8192|2.6482||15.27|958096||-12.6771|617.9815||1.75|4|25|||-0.5921|-2.5436||||||15.15|14.05
new_0222_0431|ABOS|20211115|324.105|2.4054||13.87|650277||-13.9567|561.3231||1.75|4|24||0.5983|-0.5955|-4.87|-16|-30.9123||||13.54|7.9
new_0222_0431|ABOS|20211215|177.1244|1.3146||7.58|973187||-25.5382|306.7649||||||||-3.349|-15.5002|||||8.13|6.76
new_0222_0431|ABOS|20220115|157.2622|1.1671||6.73|968444||-28.7637|272.3651||1.25|4|23.5|||||-29.4304|||||6.37|5.12
new_0222_0431|ABOS|20220215|121.9775|0.9053||5.22|||-37.0842|211.255||1.25|4|23.5|||-0.7025|-0.6021||||||4.98|5.91